Big Pharma’s covid-19 profiteers

Share it with your friends Like

Thanks! Share it with your friends!

Close

On June 29th, 2020, while America remained transfixed by anti-police protests, the chairman and CEO of the pharmaceutical company Gilead issued a much-anticipated announcement. In a breezy open letter, Daniel O’Day explained how much his company planned on charging for a course of remdesivir, one of many possible treatments for Covid-19. “In the weeks since we learned of remdesivir’s potential against Covid-19, one topic has attracted more speculation than any other: what price we might set for the medicine,” O’Day wrote, before plunging into a masterpiece of corporate doublespeak. The CEO noted a study by the National Institute of Allergy …read more

Source: Sott health news feed

    

  • Rating:
  • Views:87 views
  • Categories: Health